Literature DB >> 24915593

Histological observations one year after mechanochemical endovenous ablation of the great saphenous vein.

Ramon R J P van Eekeren1, Jan Luuk Hillebrands, Kim van der Sloot, Jean-Paul P M de Vries, Clark J Zeebregts, Michel M P J Reijnen.   

Abstract

PURPOSE: To report histological analysis of a great saphenous vein (GSV) 1 year after undergoing mechanochemical endovenous ablation (MOCA) and compare the findings with those of a healthy vein. CASE REPORT: A 59-year-old patient with bilateral GSV incompetence was treated with MOCA using the ClariVein catheter, which has a dispersion wire that rotates as liquid sclerosant is injected in the vein. After 1 year, the patient had recurrent edema of the right leg; duplex ultrasound was suspicious for recanalization. The patient was reoperated, and the deep femoral vein was explored. The GSV was completely obliterated, and its proximal part was excised and sent for histological processing. Microscopic evaluation of the MOCA-treated vein showed a circumferential disappearance of the endothelial layer and fibrosis of the vein. The media was considerably damaged, with changes in collagen structure, supporting the therapeutic effect of MOCA.
CONCLUSION: MOCA is a novel endovenous treatment modality for saphenous vein insufficiency. Results of MOCA on the cellular level are essential to optimize treatment.

Entities:  

Keywords:  ClariVein; endothelium; fibrosis; great saphenous vein; histological analysis; mechanochemical endovenous ablation; sclerosant; varicose vein; venous insufficiency

Mesh:

Substances:

Year:  2014        PMID: 24915593     DOI: 10.1583/13-4588MR.1

Source DB:  PubMed          Journal:  J Endovasc Ther        ISSN: 1526-6028            Impact factor:   3.487


  5 in total

Review 1.  Interventions for great saphenous vein incompetence.

Authors:  Jade Whing; Sandip Nandhra; Craig Nesbitt; Gerard Stansby
Journal:  Cochrane Database Syst Rev       Date:  2021-08-11

Review 2.  S2k guidelines: diagnosis and treatment of varicose veins.

Authors:  F Pannier; T Noppeney; J Alm; F X Breu; G Bruning; I Flessenkämper; H Gerlach; K Hartmann; B Kahle; H Kluess; E Mendoza; D Mühlberger; A Mumme; H Nüllen; K Rass; S Reich-Schupke; D Stenger; M Stücker; C G Schmedt; T Schwarz; J Tesmann; J Teßarek; S Werth; E Valesky
Journal:  Hautarzt       Date:  2022-04-19       Impact factor: 1.198

3.  Endovenous laser ablation versus mechanochemical ablation with ClariVein(®) in the management of superficial venous insufficiency (LAMA trial): study protocol for a randomised controlled trial.

Authors:  Clement C M Leung; Daniel Carradice; Tom Wallace; Ian C Chetter
Journal:  Trials       Date:  2016-08-24       Impact factor: 2.279

Review 4.  Current Best Practice in the Management of Varicose Veins.

Authors:  Mark Steven Whiteley
Journal:  Clin Cosmet Investig Dermatol       Date:  2022-04-06

5.  Mechanical Occlusion Chemically Assisted Ablation (MOCA) for Saphenous Vein Insufficiency: A Meta-Analysis of a Randomized Trial.

Authors:  Johanes Nugroho; Ardyan Wardhana; Cornelia Ghea
Journal:  Int J Vasc Med       Date:  2020-01-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.